Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA518544
Max Phase: Preclinical
Molecular Formula: C23H30N7O8P
Molecular Weight: 563.51
Molecule Type: Small molecule
Associated Items:
ID: ALA518544
Max Phase: Preclinical
Molecular Formula: C23H30N7O8P
Molecular Weight: 563.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOP(=O)(Cc1ccc(NC(=O)CNC(=O)[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1)OCC
Standard InChI: InChI=1S/C23H30N7O8P/c1-3-36-39(35,37-4-2)10-13-5-7-14(8-6-13)29-15(31)9-25-22(34)19-17(32)18(33)23(38-19)30-12-28-16-20(24)26-11-27-21(16)30/h5-8,11-12,17-19,23,32-33H,3-4,9-10H2,1-2H3,(H,25,34)(H,29,31)(H2,24,26,27)/t17-,18+,19-,23+/m0/s1
Standard InChI Key: ZIGQJTCDPMPONX-QPXQOZNCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 563.51 | Molecular Weight (Monoisotopic): 563.1893 | AlogP: 0.55 | #Rotatable Bonds: 11 |
Polar Surface Area: 213.04 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.76 | CX Basic pKa: 4.92 | CX LogP: -1.04 | CX LogD: -1.04 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.20 | Np Likeness Score: -0.21 |
1. Brunschweiger A, Iqbal J, Umbach F, Scheiff AB, Munkonda MN, Sévigny J, Knowles AF, Müller CE.. (2008) Selective nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) inhibitors: nucleotide mimetics derived from uridine-5'-carboxamide., 51 (15): [PMID:18630897] [10.1021/jm800175e] |
Source(1):